IN THE KNOW
Resources. Press releases.
Category
- Category
- Client news
- Press releases
TOPICS
- TOPICS
- Commercial Plans
- Diabetes
- Drug Approvals
- Drug Costs
- Formulary Management
- Fraud, Waste, Abuse
- Generics
- Innovation
- Medicaid
- Medicare Part D
- Natural Disasters
- Opioids
- Pharmacogenomics
- Pharmacy Network
- Technology
- Utilization Management
-
- Press releases
- MedImpact's Steven Avey receives AMCP Foundation's highest award.
- Avey honored for groundbreaking work that has improved countless lives, changed pharmacy benefit management
- READ MORE
-
- Client news
- Paying for cures.
- MedImpact sponsors MIT initiative to help make high-cost curative therapies more accessible
- READ MORE
-
- Client news
- Combating the opioid crisis together.
- MedImpact helps reduce opioid utilization in one of America's most affected states
- READ MORE
-
- Client news
- MedImpact activates natural disaster response in wake of Hurricane Michael.
- As Hurricane Michael — the strongest hurricane in history to hit the Florida Panhandle — continues to surge through the Southeast with damaging winds and flood-causing rains, MedImpact is committed to providing natural disaster support to our clients and members.
- READ MORE
-
- Client news
- FDA approves new preventive treatment for rare hereditary disease.
- The U.S. Food and Drug Administration (FDA) recently approved Takhzyro (lanadelumab-flyo) as the first preventive monoclonal antibody to treat hereditary angioedema (HAE) to help prevent attacks in patients 12 years and older. HAE is a rare and potentially life-threatening genetic disease that can cause unpredictable, debilitating episodes of painful swelling in the limbs, abdomen and airway.
- READ MORE
-
- Client news
- Moving toward performance-based networks.
- MedImpact discusses trends in value-based pharmacy reimbursement in Chain Drugstore Daily
- READ MORE
We are the PBM that puts clients and consumers first. Always. Ready for a change?
